Page last updated: 2024-09-02

fingolimod hydrochloride and Opportunistic Infections

fingolimod hydrochloride has been researched along with Opportunistic Infections in 6 studies

Research

Studies (6)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (16.67)	29.6817
2010's	3 (50.00)	24.3611
2020's	2 (33.33)	2.80

Authors

Authors	Studies
Harirchian, MH; Kamali, H; Poursadeghfard, M; Sadeghipour, A; Sarraf, P	1
Aktas, O; Bielor, C; Hartung, HP; Kremer, D; MacKenzie, C; Müller, AK; Weyers, V; Wienemann, T	1
Behle, V; Goebeler, M; Stoevesandt, J; Wobser, M	1
Bornstein, PF; Carpenter, AF; Goodwin, SJ; Larson, AJ; Markus, CK	1
Yamamura, T	1
Cervera, C	1

Reviews

2 review(s) available for fingolimod hydrochloride and Opportunistic Infections

Article	Year
[Molecular target drug development for curing multiple sclerosis]. Brain and nerve = Shinkei kenkyu no shinpo, 2009, Volume: 61, Issue:8 Topics: Abatacept; Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Autoimmunity; Clinical Trials as Topic; Daclizumab; Drug Discovery; Fingolimod Hydrochloride; Humans; Immunoconjugates; Immunoglobulin G; Integrin alpha4beta1; JC Virus; Leukoencephalopathy, Progressive Multifocal; Ligands; Lysophospholipids; Multiple Sclerosis; Natalizumab; Opportunistic Infections; Propylene Glycols; Receptors, Antigen, T-Cell; Sphingosine; Ustekinumab	2009
[Infections and fingolimod]. Revista de neurologia, 2012, Aug-16, Volume: 55, Issue:4 Topics: Community-Acquired Infections; Contraindications; Disease Management; Disease Susceptibility; Drug Therapy, Combination; Fingolimod Hydrochloride; Graft Rejection; Humans; Immunocompromised Host; Immunologic Memory; Immunologic Surveillance; Immunosuppressive Agents; Kidney Transplantation; Leukoencephalopathy, Progressive Multifocal; Lymphopenia; Multiple Sclerosis, Relapsing-Remitting; Opportunistic Infections; Propylene Glycols; Receptors, Lysosphingolipid; Sphingosine; Vaccination	2012

Article

Year

[Molecular target drug development for curing multiple sclerosis].

Brain and nerve = Shinkei kenkyu no shinpo, 2009, Volume: 61, Issue:8

Topics: Abatacept; Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Autoimmunity; Clinical Trials as Topic; Daclizumab; Drug Discovery; Fingolimod Hydrochloride; Humans; Immunoconjugates; Immunoglobulin G; Integrin alpha4beta1; JC Virus; Leukoencephalopathy, Progressive Multifocal; Ligands; Lysophospholipids; Multiple Sclerosis; Natalizumab; Opportunistic Infections; Propylene Glycols; Receptors, Antigen, T-Cell; Sphingosine; Ustekinumab

2009

[Infections and fingolimod].

Revista de neurologia, 2012, Aug-16, Volume: 55, Issue:4

Topics: Community-Acquired Infections; Contraindications; Disease Management; Disease Susceptibility; Drug Therapy, Combination; Fingolimod Hydrochloride; Graft Rejection; Humans; Immunocompromised Host; Immunologic Memory; Immunologic Surveillance; Immunosuppressive Agents; Kidney Transplantation; Leukoencephalopathy, Progressive Multifocal; Lymphopenia; Multiple Sclerosis, Relapsing-Remitting; Opportunistic Infections; Propylene Glycols; Receptors, Lysosphingolipid; Sphingosine; Vaccination

2012

Other Studies

4 other study(ies) available for fingolimod hydrochloride and Opportunistic Infections

Article	Year
Necrotizing fungal osteomyelitis and fingolimod, 4 years after treatment with fingolimod. Multiple sclerosis and related disorders, 2020, Volume: 41 Topics: Adult; Female; Fingolimod Hydrochloride; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Multiple Sclerosis, Relapsing-Remitting; Mycoses; Necrosis; Opportunistic Infections; Osteomyelitis	2020
Cryptococcal meningoencephalitis in an IgG BMC neurology, 2020, Apr-27, Volume: 20, Issue:1 Topics: Cryptococcosis; Female; Fingolimod Hydrochloride; Humans; Immunoglobulin G; Immunosuppressive Agents; Lymphopenia; Meningoencephalitis; Middle Aged; Multiple Sclerosis, Relapsing-Remitting; Opportunistic Infections	2020
Extensive molluscum contagiosum virus infection in a young adult receiving fingolimod. Multiple sclerosis (Houndmills, Basingstoke, England), 2016, Volume: 22, Issue:7 Topics: Adolescent; Biopsy; Fingolimod Hydrochloride; Humans; Immunocompromised Host; Immunosuppressive Agents; Male; Molluscum Contagiosum; Molluscum contagiosum virus; Multiple Sclerosis, Relapsing-Remitting; Opportunistic Infections; Risk Factors	2016
Cutaneous cryptococcosis in a patient taking fingolimod for multiple sclerosis: Here come the opportunistic infections? Multiple sclerosis (Houndmills, Basingstoke, England), 2017, Volume: 23, Issue:2 Topics: Adult; Cryptococcosis; Fingolimod Hydrochloride; Humans; Immunosuppressive Agents; Male; Middle Aged; Multiple Sclerosis; Opportunistic Infections; Recurrence	2017